A dual biomarker-targeting probe enables signal-on surface labeling of Staphylococcus aureus

Bioorg Med Chem Lett. 2023 Sep 1:93:129428. doi: 10.1016/j.bmcl.2023.129428. Epub 2023 Aug 2.

Abstract

Imaging or killing of a specific pathogen is of significance for precise therapy. Staphylococcus aureus (S. aureus) is an infectious gram-positive bacteria relying on Sortase A (SrtA) to anchor cell surface protein on peptidoglycan. We herein report signal-on labeling of S. aureus with self-quenched optical probes featuring vancomycin-conjugated SrtA substrate that is flanked by a dabcyl moiety paired with either fluorescein or eosine photosensizer (PS). SrtA-mediated cleavage of the substrate motif releases the dabcyl quencher, leading to covalent labeling of peptidoglycan with fluorescein or PS of restored photophysical property. The dual biomarked-enabled peptidoglycan labeling enables signal-on imaging and effective photodynamic destruction of S. aureus, suggesting a protheranostic approch activatable to SrtA-positive bacteria engaged in myriad diseases.

Keywords: Antibacterial photodynamic therapy; Covalent ligation; Fluorogenic labelling; Photosensitizer; Sortase A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoacyltransferases* / metabolism
  • Bacterial Proteins / metabolism
  • Fluoresceins
  • Membrane Proteins / metabolism
  • Peptidoglycan / metabolism
  • Staphylococcus aureus* / metabolism

Substances

  • Peptidoglycan
  • 4-(4-dimethylaminophenylazo)benzoic acid
  • Bacterial Proteins
  • Aminoacyltransferases
  • Membrane Proteins
  • Fluoresceins